Decreased GnRH Secretion [PE] - N0000008638

Pharmacologic Class Information

Pharmacologic Code N0000008638
Pharmacologic Name Decreased GnRH Secretion
Pharmacologic Uses
  • GnRH receptor antagonist
  • gonadotropin-releasing hormone (GnRH) receptor antagonist
Pharmacologic Concept Physiologic Effects - [PE]
Pharmacologic Concept Description This concept refers to the tissue, organ, or organ system effects of drug generic ingredients, organized into an organ system classification hierarchy, beneath the "Physiological Effects [PE]" concept.

NDC Products with Decreased GnRH Secretion

The following table contains 7 products whose active ingredient are classified under the same pharmacologic class Decreased GnRH Secretion [PE].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0548-5001Ganirelix Acetate Non-Proprietary Name: Ganirelix AcetateInjectionSubcutaneousAmphastar Pharmaceuticals, Inc.ACTIVE
55566-1000Ganirelix Acetate Non-Proprietary Name: Ganirelix AcetateInjection, SolutionSubcutaneousFerring Pharmaceuticals Inc.ACTIVE
55566-1010Fyremadel Non-Proprietary Name: Ganirelix AcetateInjection, SolutionSubcutaneousFerring Pharmaceuticals Inc.ACTIVE
71288-554Ganirelix Acetate Non-Proprietary Name: Ganirelix AcetateInjection, SolutionSubcutaneousMeitheal Pharmaceuticals Inc.ACTIVE
72974-120Orgovyx Non-Proprietary Name: RelugolixTablet, Film CoatedOralMyovant Sciences, Inc.ACTIVE
72974-415Myfembree Non-Proprietary Name: Relugolix, Estradiol Hemihydrate, And Norethindrone AcetateTablet, Film CoatedOralMyovant Sciences, Inc.ACTIVE
78206-138Ganirelix Acetate Non-Proprietary Name: Ganirelix AcetateInjection, SolutionSubcutaneousOrganon LlcACTIVE